Filana Therapeutics, Inc. (FLNA) News
Follow Filana Therapeutics, Inc. (FLNA) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
FDA lifts clinical hold on Filana’s simufilam for TSC-related epilepsy
TradingView News reports the FDA lifted the clinical hold on Filana’s simufilam for TSC-related epilepsy.
EQUITY | Sep 22, 2026, 12:45 PM UTC
M
FDA lifts clinical hold on simufilam IND; Phase 2a in TSC epilepsy
Filana Therapeutics said the FDA lifted the clinical hold on its IND for simufilam, enabling a planned Phase 2a study in TSC-related epilepsy, with screening expected to begin by Q1 2027.
REGULATION | Sep 22, 2026, 12:04 PM UTC
L
FLNA - Did Filana Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
FLNA - Did Filana Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
EQUITY | Aug 12, 2026, 06:21 PM UTC
L
FLNA - Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update
FLNA - Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update
EARNINGS | Jul 29, 2026, 12:00 PM UTC